AtriCure Inc (NAS:ATRC)
$ 36.16 -0.01 (-0.03%) Market Cap: 1.76 Bil Enterprise Value: 1.71 Bil PE Ratio: 0 PB Ratio: 3.79 GF Score: 77/100

Q3 2022 AtriCure Inc Earnings Call Transcript

Nov 01, 2022 / 08:30PM GMT
Release Date Price: $42.94 (+1.95%)
Operator

Good afternoon, and welcome to AtriCure's Q3 2022 Earnings Conference Call. My name is Stacy, and I'll be your coordinator for the call today. (Operator Instructions)

I would like to turn the call over to Marissa Bych from the Gilmartin Group for a few introductory comments.

Marissa Bych
Gilmartin Group

Thank you. By now, you should have received a copy of the earnings press release. If you have not received a copy, please call 513-644-4484 to have one e-mailed to you.

Before we begin, let me remind you that the company's remarks include forward-looking statements. Forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond AtriCure's control, including risks and uncertainties described from time to time in AtriCure's SEC filings. These statements include, but are not limited to, financial expectations and guidance, expectations regarding the potential market opportunity for AtriCure's franchises and growth initiatives, including the adoption of the Hybrid AF therapy and future product approvals,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot